Skip to main content
  • Challenge:Future Innovator Prize
  • Phase:Seed
  • Team Lead:Martin O’Sullivan; Liosa O’Sullivan
  • Team Co-Lead:Dr Brian O’Donnell; Dr Eric Moore
SMARTProbe

Breast cancer is the 2nd most commonly diagnosed cancer in women

1 in 9 women will develop breast cancer in the course of their lifetime

Ireland ranked 4th highest mortality rate in Europe

Incidence rate of breast cancer is on the increase

Approximately 3000 new cases of breast cancer diagnosed last year

No real-time diagnosis available so all biopsies go the laboratory even though approximately 80% are benign

8 – 10 day wait for patient diagnosis

Significant distress & anxiety for patient & families waiting for results

SMARTProbe will provide real-time point of care enhancement of breast cancer diagnosis.

disruptive-gene-editing

SepTec